|
"jia horng kao"的相關文件
顯示項目 866-890 / 1180 (共48頁)
<< < 30 31 32 33 34 35 36 37 38 39 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T14:50:07Z |
Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: optimizing use of peginterferon alfa.
|
Liu, Chen-Hua;Kao, Jia-Horng; Liu, Chen-Hua; CHEN-HUA LIU; JIA-HORNG KAO; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T09:49:32Z |
Fluvastatin helps interferon-based therapy in chronic hepatitis C: Fact or fiction?
|
Hsu, Ching-Sheng;Kao, Jia-Horng; Hsu, Ching-Sheng; JIA-HORNG KAO; Kao, Jia-Horng; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T09:49:32Z |
Interferon-Based Therapy Decreases Risks of Hepatocellular Carcinoma and Complications of Cirrhosis in Chronic Hepatitis C Patients
|
Hsu, Ching-Sheng; Huang, Chun-Jen; Kao, Jia-Horng; Lin, Hans Hsienhong; Chao, You-Chen; Fan, Yen-Chun; Tsai, Pei-Shan; Polis, Michael Alan; JIA-HORNG KAO; Hsu, Ching-Sheng; Huang, Chun-Jen; Kao, Jia-Horng; Kao, Jia-Horng; Lin, Hans Hsienhong; Lin, Hans Hsienhong; Chao, You-Chen; Fan, Yen-Chun; Fan, Yen-Chun; Tsai, Pei-Shan; Tsai, Pei-Shan; Polis, Michael Alan |
| 臺大學術典藏 |
2018-09-10T09:49:32Z |
Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: A population-based cohort study in Taiwan
|
Hsu, C.-S.;Kao, J.-H.;Chao, Y.-C.;Lin, H.H.;Fan, Y.-C.;Huang, C.-J.;Tsai, P.-S.; Hsu, C-S; JIA-HORNG KAO; Kao, J-H; Kao, J-H; Chao, Y-C; Lin, H. H.; Lin, H. H.; Fan, Y-C; Fan, Y-C; Huang, C-J; Huang, C-J; Tsai, P-S |
| 臺大學術典藏 |
2018-09-10T09:49:32Z |
Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype
|
Huang, Chung-Feng;Yu, Ming-Lung;Kao, Jia-Horng;Tseng, Tai-Chung;Yeh, Ming-Lun;Huang, Jee-Fu;Dai, Chia-Yen;Lin, Zu-Yau;Chen, Shinn-Cherng;Wang, Liang-Yen;Juo, Suh-Hang Hank;Chuang, Wan-Long;Liu, Chen-Hua; CHEN-HUA LIU; Huang, Chung-Feng; Yu, Ming-Lung; JIA-HORNG KAO; Kao, Jia-Horng; Kao, Jia-Horng; Tseng, Tai-Chung; Tseng, Tai-Chung; Yeh, Ming-Lun; Yeh, Ming-Lun; Huang, Jee-Fu; Dai, Chia-Yen; Lin, Zu-Yau; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chuang, Wan-Long; Chuang, Wan-Long; Liu, Chen-Hua; Liu, Chen-Hua |
| 臺大學術典藏 |
2018-09-10T09:49:32Z |
Global perspective on the natural history of chronic hepatitis B: Role of hepatitis B virus genotypes A to J
|
Liu, Chun-Jen;Kao, Jia-Horng; Liu, Chun-Jen; Liu, Chun-Jen; CHUN-JEN LIU; JIA-HORNG KAO; Kao, Jia-Horng; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T09:49:32Z |
Hepatitis B viral factors and treatment responses in chronic hepatitis B
|
Lin, Chih-Lin;Kao, Jia-Horng; Lin, Chih-Lin; Lin, Chih-Lin; JIA-HORNG KAO; Kao, Jia-Horng; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T09:49:31Z |
Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: New trick of old dog
|
Tseng, Tai-Chung;Kao, Jia-Horng; Tseng, Tai-Chung; Tseng, Tai-Chung; JIA-HORNG KAO; Kao, Jia-Horng; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T09:49:30Z |
Consolidation therapy for HBeAg-positive Asian chronic hepatitis B patients receiving lamivudine treatment: A multicentre study
|
Wong, Grace Lai Hung; JIA-HORNG KAO; Huang, Jee-Fu; Wong, Vincent Wai Sun; Wong, Vincent Wai Sun; Liu, Chun-Jen; Liu, Chun-Jen; Yu, Ming-Lung; Chuang, Wan-Long; Chuang, Wan-Long; Kao, Jia-Horng; Kao, Jia-Horng; Chan, Henry Lik Yuen; Chen, Ding-Shinn; Chen, Ding-Shinn; Tseng, Tai-Chung; Wong, Grace Lai Hung; DING-SHINN CHEN; Dai, Chia-Yen; CHUN-JEN LIU; Dai, Chia-Yen;Tseng, Tai-Chung;Wong, Grace Lai Hung;Huang, Jee-Fu;Wong, Vincent Wai Sun;Liu, Chun-Jen;Yu, Ming-Lung;Chuang, Wan-Long;Kao, Jia-Horng;Chan, Henry Lik Yuen;Chen, Ding-Shinn |
| 臺大學術典藏 |
2018-09-10T09:49:24Z |
Increased risk of cirrhosis and its decompensation in chronic hepatitis B patients with newly diagnosed diabetes: A nationwide cohort study
|
Huang, Yi-Wen;Wang, Ting-Chuan;Lin, Shih-Chang;Chang, Han-Yu;Chen, Ding-Shinn;Hu, Jui-Ting;Yang, Sien-Sing;Kao, Jia-Horng; YI-WEN HUANG; Huang, Yi-Wen; Huang, Yi-Wen; Wang, Ting-Chuan; DING-SHINN CHEN; JIA-HORNG KAO; Lin, Shih-Chang; Chang, Han-Yu; Chen, Ding-Shinn; Chen, Ding-Shinn; Hu, Jui-Ting; Yang, Sien-Sing; Kao, Jia-Horng; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T09:49:23Z |
Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers
|
Tseng, T.-C., Liu, C.-J., Chen, C.-L., Yang, H.-C., Su, T.-H., Wang, C.-C., Yang, W.-T., Kuo, S.F.-T., Liu, C.-H., Chen, P.-J., Chen, D.-S., Kao, J.-H.; HUNG-CHIH YANG; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; TUNG-HUNG SU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T09:49:23Z |
IL-21R gene polymorphisms and serum IL-21 levels predict virological response to interferon-based therapy in Asian chronic hepatitis C patients
|
Hsu, Ching-Sheng;Hsu, Shih-Jer;Liu, Wei-Liang;Chen, Chi-Ling;Liu, Chun-Jen;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; CHUN-JEN LIU; Hsu, Ching-Sheng; PEI-JER CHEN; Hsu, Shih-Jer; Liu, Wei-Liang; DING-SHINN CHEN; Chen, Chi-Ling; JIA-HORNG KAO; Liu, Chun-Jen; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T09:49:22Z |
Hepatitis B virus reactivation in patients receiving cancer chemotherapy: Natural history, pathogenesis, and management
|
JIA-HORNG KAO; Kao, Jia-Horng; Liu, Chun-Jen;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Liu, Chun-Jen; Liu, Chun-Jen; CHUN-JEN LIU; Chen, Pei-Jer; PEI-JER CHEN; Chen, Pei-Jer; DING-SHINN CHEN; Chen, Ding-Shinn; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T09:49:22Z |
Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection
|
Su, T.-H., Liu, C.-J., Tseng, T.-C., Liu, C.-H., Yang, H.-C., Chen, C.-L., Chen, P.-J., Kao, J.-H., Chen, D.-S.; Su, Tung-Hung;Liu, Chun-Jen;Tseng, Tai-Chung;Liu, Chen-Hua;Yang, Hung-Chih;Chen, Chi-Ling;Chen, Pei-Jer;Kao, Jia-Horng;Chen, Ding-Shinn; 陳定信 ;劉振驊 ;高嘉宏 ;楊宏志 ;蘇東弘 ;劉俊人 ;陳培哲 ;陳祈玲; Su, Tung-Hung; Su, Tung-Hung; CHUN-JEN LIU; Liu, Chun-Jen; Liu, Chun-Jen; PEI-JER CHEN; CHEN-HUA LIU; Tseng, Tai-Chung; Liu, Chen-Hua; DING-SHINN CHEN; Liu, Chen-Hua; TUNG-HUNG SU; Yang, Hung-Chih; Yang, Hung-Chih; Chen, Chi-Ling; JIA-HORNG KAO; Chen, Pei-Jer; Chen, Pei-Jer; Kao, Jia-Horng; Kao, Jia-Horng; Chen, Ding-Shinn; Chen, Ding-Shinn |
| 臺大學術典藏 |
2018-09-10T09:47:27Z |
Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients
|
Hsu, Ching-Sheng;Hsu, Shih-Jer;Chen, Hung-Chia;Liu, Chen-Hua;Jeng, Jenher;Liu, Chun-Jen;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; CHUN-JEN LIU; Hsu, Ching-Sheng; Hsu, Ching-Sheng; PEI-JER CHEN; Hsu, Shih-Jer; Hsu, Shih-Jer; CHEN-HUA LIU; Chen, Hung-Chia; Chen, Hung-Chia; Liu, Chen-Hua; DING-SHINN CHEN; Liu, Chen-Hua; Jeng, Jenher; JIA-HORNG KAO; Liu, Chun-Jen; Liu, Chun-Jen; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T09:47:26Z |
Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion
|
Yang, Hung-Chih;Chen, Chi-Ling;Shen, Yueh-Chi;Peng, Cheng-Yuan;Liu, Chun-Jen;Tseng, Tai-Chung;Su, Tung-Hung;Chuang, Wan-Long;Yu, Ming-Lung;Dai, Chia-Yen;Liu, Chen-Hua;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Yang, Hung-Chih;Chen, Chi-Ling;Shen, Yueh-Chi;Peng, Cheng-Yuan;Liu, Chun-Jen;Tseng, Tai-Chung;Su, Tung-Hung;Chuang, Wan-Long;Yu, Ming-Lung;Dai, Chia-Yen;Liu, Chen-Hua;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Yang, H.-C. and Chen, C.-L. and Shen, Y.-C. and Peng, C.-Y. and Liu, C.-J. and Tseng, T.-C. and Su, T.-H. and Chuang, W.-L. and Yu, M.-L. and Dai, C.-Y. and Liu, C.-H. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H.; 陳定信 ;劉振驊 ;高嘉宏 ;楊宏志 ;蘇東弘 ;劉俊人 ;陳培哲 ;陳祈玲; Yang, Hung-Chih; HUNG-CHIH YANG; CHUN-JEN LIU; Chen, Chi-Ling; Shen, Yueh-Chi; PEI-JER CHEN; Peng, Cheng-Yuan; CHEN-HUA LIU; TUNG-HUNG SU; Liu, Chun-Jen; Liu, Chun-Jen; Tseng, Tai-Chung; DING-SHINN CHEN; Tseng, Tai-Chung; Su, Tung-Hung; Su, Tung-Hung; JIA-HORNG KAO; Chuang, Wan-Long; Yu, Ming-Lung; Dai, Chia-Yen; Liu, Chen-Hua; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Chen, Ding-Shinn; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T09:47:25Z |
Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patients
|
Yuan, Quan;Song, Liu-Wei;Liu, Chun-Jen;Li, Zhuo;Liu, Ping-Guo;Huang, Cheng-Hao;Yan, Yan;Ge, Sheng-Xiang;Wang, Ying-Bin;Peng, Cheng-Yuan;Zhang, Jun;Kao, Jia-Horng;Chen, Ding-Shinn;Chen, Pei-Jer;Xia, Ning-Shao; CHUN-JEN LIU; Yuan, Quan; Song, Liu-Wei; PEI-JER CHEN; DING-SHINN CHEN; Liu, Chun-Jen; JIA-HORNG KAO; Li, Zhuo; Liu, Ping-Guo; Huang, Cheng-Hao; Yan, Yan; Ge, Sheng-Xiang; Wang, Ying-Bin; Peng, Cheng-Yuan; Zhang, Jun; Kao, Jia-Horng; Chen, Ding-Shinn; Chen, Pei-Jer; Xia, Ning-Shao |
| 臺大學術典藏 |
2018-09-10T09:47:24Z |
Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C
|
Su, Tung-Hung;Liu, Chen-Hua;Liu, Chun-Jen;Chen, Chi-Ling;Ting, Te-Tien;Tseng, Tai-Chung;Chen, Pei-Jer;Kao, Jia-Horng;Chen, Ding-Shinn; Su, Tung-Hung;Liu, Chen-Hua;Liu, Chun-Jen;Chen, Chi-Ling;Ting, Te-Tien;Tseng, Tai-Chung;Chen, Pei-Jer;Kao, Jia-Horng;Chen, Ding-Shinn; Su, T.-H. and Liu, C.-H. and Liu, C.-J. and Chen, C.-L. and Ting, T.-T. and Tseng, T.-C. and Chen, P.-J. and Kao, J.-H. and Chen, D.-S.; 陳定信 ;劉振驊 ;高嘉宏 ;蘇東弘 ;劉俊人 ;陳培哲 ;陳祈玲; Su, Tung-Hung; Su, Tung-Hung; CHUN-JEN LIU; Liu, Chen-Hua; Liu, Chen-Hua; PEI-JER CHEN; CHEN-HUA LIU; Liu, Chun-Jen; Liu, Chun-Jen; Chen, Chi-Ling; TUNG-HUNG SU; Ting, Te-Tien; DING-SHINN CHEN; JIA-HORNG KAO; Tseng, Tai-Chung; Chen, Pei-Jer; Chen, Pei-Jer; Kao, Jia-Horng; Kao, Jia-Horng; Chen, Ding-Shinn; Chen, Ding-Shinn; 陳祈玲 |
| 臺大學術典藏 |
2018-09-10T09:41:15Z |
Biphasic pattern of depression and its predictors during pegylated interferon-based therapy in chronic hepatitis B and C patients
|
Huang, Yi-Wen;Hu, Jui-Ting;Hu, Fu-Chang;Chang, Ching-Jui;Chang, Han-Yu;Kao, Jia-Horng;Yang, Sien-Sing;Chen, Ding-Shinn; Huang, Yi-Wen; Huang, Yi-Wen; YI-WEN HUANG; Hu, Jui-Ting; Hu, Jui-Ting; DING-SHINN CHEN; JIA-HORNG KAO; Hu, Fu-Chang; Chang, Ching-Jui; Chang, Han-Yu; Kao, Jia-Horng; Kao, Jia-Horng; Yang, Sien-Sing; Yang, Sien-Sing; Chen, Ding-Shinn; Chen, Ding-Shinn |
| 臺大學術典藏 |
2018-09-10T09:40:00Z |
IL28B genotype on HCV infection in Asia
|
Liu, C.-H.;Kao, J.-H.; CHEN-HUA LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T09:39:55Z |
Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up.
|
Yu, Ming-Lung; HUNG-CHIH YANG; CHUN-JEN LIU; Lee, Chuan-Mo; Lee, Chuan-Mo; PEI-JER CHEN; Chen, Chi-Ling; Chen, Chi-Ling; CHEN-HUA LIU; Chuang, Wan-Long; Lu, Sheng-Nan; Lu, Sheng-Nan; DING-SHINN CHEN; Liu, Chen-Hua; JIA-HORNG KAO; Liu, Chen-Hua; Wu, Shun-Sheng; Wu, Shun-Sheng; Liao, Li-Ying; Kuo, Hsing-Tao; Kuo, Hsing-Tao; Chao, You-Chen; Tung, Shui-Yi; Tung, Shui-Yi; Yang, Sien-Sing; Kao, Jia-Horng; Kao, Jia-Horng; Su, Wei-Wen; Su, Wei-Wen; Lin, Chih-Lin; Lin, Chih-Lin; Yang, Hung-Chih; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Chen, Ding-Shinn; Liu, Chun-Jen; Liu, Chun-Jen; Yu, Ming-Lung;Lee, Chuan-Mo;Chen, Chi-Ling;Chuang, Wan-Long;Lu, Sheng-Nan;Liu, Chen-Hua;Wu, Shun-Sheng;Liao, Li-Ying;Kuo, Hsing-Tao;Chao, You-Chen;Tung, Shui-Yi;Yang, Sien-Sing;Kao, Jia-Horng;Su, Wei-Wen;Lin, Chih-Lin;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Liu, Chun-Jen |
| 臺大學術典藏 |
2018-09-10T09:39:55Z |
Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads.
|
Tseng, Tai-Chung;Liu, Chun-Jen;Yang, Hung-Chih;Su, Tung-Hung;Wang, Chia-Chi;Chen, Chi-Ling;Hsu, Cheng-An;Kuo, Stephanie Fang-Tzu;Liu, Chen-Hua;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; 陳定信 ;劉振驊 ;高嘉宏 ;楊宏志 ;蘇東弘 ;劉俊人 ;陳培哲 ;陳祈玲; CHUN-JEN LIU; Tseng, Tai-Chung; Tseng, Tai-Chung; Liu, Chun-Jen; PEI-JER CHEN; Yang, Hung-Chih; CHEN-HUA LIU; TUNG-HUNG SU; Su, Tung-Hung; DING-SHINN CHEN; Wang, Chia-Chi; Wang, Chia-Chi; Chen, Chi-Ling; Hsu, Cheng-An; Hsu, Cheng-An; Kuo, Stephanie Fang-Tzu; Kuo, Stephanie Fang-Tzu; Liu, Chen-Hua; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Chen, Ding-Shinn; Kao, Jia-Horng; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T09:23:50Z |
Advances in the treatment of chronic hepatitis C: From interferon to direct acting anti-virals
|
Liu, C.-J.;Hsu, C.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T09:23:50Z |
Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update
|
Liu, Chun-Jen; Gane, Ed; Locarnini, Stephen; Lim, Seng-Gee; Han, Kwang-Hyub; Amarapurkar, Deepak; Cooksley, Graham; Jafri, Wasim; Mohamed, Rosmawati; Mohamed, Rosmawati; Hou, Jin-Lin; Hou, Jin-Lin; Chuang, Wan-Long; Chuang, Wan-Long; Lesmana, Laurentius A.; Sollano, Jose D.; Sollano, Jose D.; Suh, Dong-Jin; Suh, Dong-Jin; Omata, Masao; Chien, Rong-Nan; Chan, Henry Lik Yuen; Piratvisuth, Teerha; Kao, Jia-Horng; Kao, Jia-Horng; JIA-HORNG KAO; Liaw, Yun-Fan; CHUN-JEN LIU; Liaw, Yun-Fan;Kao, Jia-Horng;Piratvisuth, Teerha;Chan, Henry Lik Yuen;Chien, Rong-Nan;Liu, Chun-Jen;Gane, Ed;Locarnini, Stephen;Lim, Seng-Gee;Han, Kwang-Hyub;Amarapurkar, Deepak;Cooksley, Graham;Jafri, Wasim;Mohamed, Rosmawati;Hou, Jin-Lin;Chuang, Wan-Long;Lesmana, Laurentius A.;Sollano, Jose D.;Suh, Dong-Jin;Omata, Masao |
| 臺大學術典藏 |
2018-09-10T09:23:50Z |
Genomic variation-guided management in chronic hepatitis C
|
Hsu, Ching-Sheng;Kao, Jia-Horng; Hsu, Ching-Sheng; JIA-HORNG KAO; Kao, Jia-Horng; Kao, Jia-Horng |
顯示項目 866-890 / 1180 (共48頁)
<< < 30 31 32 33 34 35 36 37 38 39 > >>
每頁顯示[10|25|50]項目
|
